Drug class
Recombinant activated human coagulation factor VIIa (rFVIIa; bypassing haemostatic agent)
Mechanism of action
Activated factor VII binds tissue factor and activates factor X and, on activated platelet surfaces, factor IX; this supports local thrombin generation and fibrin formation even when factor VIII or IX activity is inhibited or deficient.
General use cases
- Treatment of bleeding episodes and prevention of bleeding during surgery or invasive procedures in defined patients with congenital haemophilia and factor VIII/IX inhibitors, acquired haemophilia, congenital factor VII deficiency or Glanzmann thrombasthenia with platelet-transfusion refractoriness; exact eligibility is product-specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
